Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2010 1
2014 1
2015 1
2016 1
2017 1
2018 2
2019 4
2020 3
2021 3
2022 2
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography.
Román M, Louro J, Posso M, Vidal C, Bargalló X, Vázquez I, Quintana MJ, Alcántara R, Saladié F, Del Riego J, Peñalva L, Sala M, Castells X, On Behalf Of The Bele And Iris Study Groups. Román M, et al. Among authors: saladie f. Int J Environ Res Public Health. 2022 Feb 24;19(5):2625. doi: 10.3390/ijerph19052625. Int J Environ Res Public Health. 2022. PMID: 35270331 Free PMC article.
Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening.
Louro J, Román M, Posso M, Vázquez I, Saladié F, Rodriguez-Arana A, Quintana MJ, Domingo L, Baré M, Marcos-Gragera R, Vernet-Tomas M, Sala M, Castells X; BELE and IRIS Study Groups. Louro J, et al. Among authors: saladie f. PLoS One. 2021 Mar 23;16(3):e0248930. doi: 10.1371/journal.pone.0248930. eCollection 2021. PLoS One. 2021. PMID: 33755692 Free PMC article.
Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X; BELE study group. Posso M, et al. Among authors: saladie f. Eur Radiol. 2022 Jan;32(1):621-629. doi: 10.1007/s00330-021-08118-y. Epub 2021 Jun 22. Eur Radiol. 2022. PMID: 34156554
Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features.
Castells X, Torá-Rocamora I, Posso M, Román M, Vernet-Tomas M, Rodríguez-Arana A, Domingo L, Vidal C, Baré M, Ferrer J, Quintana MJ, Sánchez M, Natal C, Espinàs JA, Saladié F, Sala M; BELE Study Group. Castells X, et al. Among authors: saladie f. Radiology. 2016 Aug;280(2):379-86. doi: 10.1148/radiol.2016151174. Epub 2016 Feb 15. Radiology. 2016. PMID: 26878225
Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall.
Vernet-Tomás M, Louro J, Román M, Saladié F, Posso M, Prieto M, Vázquez I, Baré M, Peñalva L, Vidal C, Bargalló X, Sánchez M, Ferrer J, A Espinàs J, Quintana MJ, Rodríguez-Arana A, Castells X; BELE study group. Vernet-Tomás M, et al. Among authors: saladie f. Maturitas. 2021 Feb;144:53-59. doi: 10.1016/j.maturitas.2020.10.024. Epub 2020 Nov 4. Maturitas. 2021. PMID: 33358209
Changes in colorectal cancer incidence and mortality trends in Spain.
López-Abente G, Ardanaz E, Torrella-Ramos A, Mateos A, Delgado-Sanz C, Chirlaque MD; Colorectal Cancer Working Group. López-Abente G, et al. Ann Oncol. 2010 May;21 Suppl 3:iii76-82. doi: 10.1093/annonc/mdq091. Ann Oncol. 2010. PMID: 20427364 Free article.
Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.
Posso M, Corominas JM, Serrano L, Román M, Torá-Rocamora I, Domingo L, Romero A, Quintana MJ, Vernet-Tomas M, Baré M, Vidal C, Sánchez M, Saladié F, Natal C, Ferrer J, Servitja S, Sala M, Castells X; BELE Study Group. Posso M, et al. Among authors: saladie f. Cancer Med. 2017 Jun;6(6):1482-1489. doi: 10.1002/cam4.1080. Epub 2017 May 4. Cancer Med. 2017. PMID: 28470951 Free PMC article.
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study.
Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, Katalinic A, Majuelo LG, Marcos-Gragera R, Molinié F, Rapiti E, Vizcaino A, Zadnik V, Minicozzi P; European High Resolution Working Group on breast cancer. Sant M, et al. Breast Cancer Res Treat. 2020 Sep;183(2):439-450. doi: 10.1007/s10549-020-05761-9. Epub 2020 Jul 10. Breast Cancer Res Treat. 2020. PMID: 32651753
17 results